Skip to main content

Emily Mullin

Staff Writer

Emily Mullin is a staff writer at WIRED, covering biotechnology. Previously, she was an MIT Knight Science Journalism project fellow and a staff writer covering biotechnology at Medium's OneZero. Before that, she served as an associate editor at MIT Technology Review, where she wrote about biomedicine. Her stories have also appeared in National Geographic, Scientific American, Smithsonian Magazine and The Washington Post, among other outlets. She has a master's degree in science writing from Johns Hopkins University.

There’s New Proof Crispr Can Edit Genes Inside Human Bodies

The technique had largely been limited to editing patients’ cells in the lab. New research shows promise for treating diseases more directly.

How a ‘Living Drug’ Could Treat Autoimmune Disease

CAR-T therapy has been successful at treating cancer. Now, it’s driven lupus into remission in a handful of patients.

A GMO Purple Tomato Is Coming to Stores. Will the US Bite?

Most genetically engineered foods were developed to aid farmers. This one will try to sway over health-conscious produce shoppers.

How Does a Variant-Specific Covid Booster Work?

The latest vaccines are designed to target the currently circulating Omicron variants—and head off a winter surge.

An Effort to ID Tulsa Race Massacre Victims Raises Privacy Issues

The project will match the victims’ DNA to that of their descendants—but uses a genealogy website that can be accessed by law enforcement.

This Man Set the Record for Wearing a Brain-Computer Interface

Implanted devices let people control computers and prosthetic limbs with their minds. But nobody knows how long they’ll last—and when they’ll need upgrades.

Police Used a Baby’s DNA to Investigate Its Father for a Crime

Small pinpricks of blood are used to screen newborns for serious health conditions—but this genetic data can have legal uses too.

A Bioengineered Cornea Shows It Can Improve People’s Sight

Donated human corneas are scarce in places where they’re most needed. A version made from pig collagen could help meet demand.

The Pigs Died. Then Scientists Revived Their Cells

A new system for keeping body tissues functional after death could help make more organs available for transplant.

There’s a Monkeypox Testing Bottleneck

US testing capacity has ramped up, but the process is ponderous, and not everyone who needs a test is getting one.

California Wants to Make Cheap Insulin. Here’s How It Could Work

The state plans to roll out “biosimilars” that mimic brand-name versions at a dramatically reduced price.

After Roe, Men Might Finally Get Better Birth Control

Men don’t have many options when it comes to pregnancy prevention—but the time may finally be right for a men’s version of the pill.

The Covid Virus Keeps Evolving. Why Haven't Vaccines?

Updating the shots to adapt to rapidly changing variants is easier said than done, even with new mRNA technology.

A New Kind of Genome Editing Is Here to Fine-Tune DNA

Instead of deleting genes, epigenetic editing modulates their activity. A new paper tests if it’s able to undo a genetic effect of early alcohol exposure.

Australia Moves Ahead Cautiously With '3-Parent IVF'

The nation follows the UK in permitting mitochondrial donation, which aims to prevent the transmission of rare but often fatal conditions.

The First Drug-Releasing Contact Lens Is Here

The FDA has approved daily disposables that release anti-allergy medication. Experts hope lenses could one day help treat cataracts and glaucoma.

Police Used a Rape Survivor's DNA to Link Her to Another Crime

A controversial California case has raised questions about police use of DNA databases and the need for better genetic privacy laws.

Could Crispr Flip the Switch on Insecticide Resistance?

Many insects, like the mosquitoes that spread malaria, have evolved a tolerance to chemical sprays. What if we could reboot their genes?

States Are Toughening Up Privacy Laws for At-Home DNA Tests

California’s SB 41 is the latest to tighten regulations on the sensitive data collected by companies like 23andMe or Ancestry.

‘Neurograins’ Could be the Next Brain-Computer Interfaces

Dozens of microchips scattered over the cortical surface might allow researchers to listen in on thousands of neurons at the same time.